Tag: Boehringer Ingelheim

Hikma Acquires Roxane Laboratories

July 29, 2015 / 2845 views

In a move that is set to transform its position in the US generics market, Hikma Pharmaceuticals has announced that it is acquiring Roxane Laboratories for JD1.88 billion ($2.65 billion) in cash and stock. Hikma, which was one of a number…

Hikma to graduate to FTSE 100

March 8, 2015 / 3458 views

Hikma Pharmaceuticals is set this month to take its place alongside GlaxoSmithKline, AstraZeneca and Shire as a fourth blue-chip drug maker on the FTSE 100, Britain’s benchmark share index. Hikma will push Tullow Oil out of the esteemed club of…